Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
The Proteasome02:18

The Proteasome

9.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.1K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K
The Proteasome Structure01:17

The Proteasome Structure

999
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
999
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

12.8K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
12.8K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome.

Journal of medicinal chemistry·2025
Same author

Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders.

ACS medicinal chemistry letters·2025
Same author

Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023.

Expert opinion on therapeutic patents·2024
Same author

Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023.

Expert opinion on therapeutic patents·2024
Same author

Photocatalyzed Decarboxylative Addition of N-Substituted Acetic Acids to Aldehydes.

The Journal of organic chemistry·2023
Same author

Covalent Enzyme Inhibition through Fluorosulfate Modification of a Noncatalytic Serine Residue.

ACS chemical biology·2017

Related Experiment Video

Updated: Sep 21, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.1K

Selectivity through Targeted Protein Degradation (TPD).

Ariamala Gopalsamy1

  • 1Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Journal of Medicinal Chemistry
|June 6, 2022
PubMed
Summary

PROTACs (proteolysis targeting chimeras) offer unique advantages for targeted protein degradation. Achieving selectivity involves factors like ternary complex conformation and protein expression levels, moving towards rational design.

More Related Videos

Tuning Degradation to Achieve Specific and Efficient Protein Depletion
05:11

Tuning Degradation to Achieve Specific and Efficient Protein Depletion

Published on: July 20, 2019

6.3K
Growth-based Determination and Biochemical Confirmation of Genetic Requirements for Protein Degradation in Saccharomyces cerevisiae
10:57

Growth-based Determination and Biochemical Confirmation of Genetic Requirements for Protein Degradation in Saccharomyces cerevisiae

Published on: February 16, 2015

9.9K

Related Experiment Videos

Last Updated: Sep 21, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

10.1K
Tuning Degradation to Achieve Specific and Efficient Protein Depletion
05:11

Tuning Degradation to Achieve Specific and Efficient Protein Depletion

Published on: July 20, 2019

6.3K
Growth-based Determination and Biochemical Confirmation of Genetic Requirements for Protein Degradation in Saccharomyces cerevisiae
10:57

Growth-based Determination and Biochemical Confirmation of Genetic Requirements for Protein Degradation in Saccharomyces cerevisiae

Published on: February 16, 2015

9.9K

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Targeted protein degradation using PROTACs (proteolysis targeting chimeras) is a rapidly advancing field in medicinal chemistry.
  • Degraders offer advantages over traditional drugs by targeting proteins lacking functional or scaffolding roles.
  • Achieving selectivity among closely related protein targets remains a challenge in degrader design.

Purpose of the Study:

  • To analyze reported examples of degrader selectivity.
  • To identify key factors hypothesized to contribute to achieving selectivity in targeted protein degradation.
  • To explore the potential for a rational design approach to degrader selectivity.

Main Methods:

  • Review and analysis of published PROTACs and other targeted protein degraders.
  • Hypothesis generation based on reported selectivity data.
  • Discussion of structural and biological factors influencing degrader efficacy and selectivity.

Main Results:

  • Ternary complex conformation, specifically access to key lysine residues, is a significant factor for selectivity.
  • Other contributing factors include protein/E3 ligase expression levels, tissue-specific expression, resynthesis rates, ubiquitination rates, and ternary complex stability.
  • Selectivity among closely related targets has been achieved in some cases.

Conclusions:

  • While degrader design is currently empirical, several factors are crucial for achieving selectivity.
  • Continued progress in determining ternary complex structures and employing predictive modeling will facilitate a rational design approach.
  • A rational strategy for achieving targeted protein degradation and selectivity is becoming increasingly attainable.